BNP Paribas Financial Markets
COYA icon

BNP Paribas Financial Markets’s Coya Therapeutics COYA Stock Holding History

BNP Paribas Financial Markets’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.7K Buy
+8,563
New +$40K ﹤0.01% 4891

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BNP Paribas Financial Markets's COYA Position: Q1 2026 in Review

BNP Paribas Financial Markets opened a new position in Coya Therapeutics (COYA) in Q1 2026: 8,563 shares worth $33.7K. The stake represents ﹤0.01% of the portfolio and ranks #4891 among its holdings.

56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • BNP Paribas Financial Markets held 8,563 shares of Coya Therapeutics worth $33.7K as of Q1 2026.
  • Coya Therapeutics was a new BNP Paribas Financial Markets position in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4891 holding.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.